• Korean Journal of Animal Reproduction
• /
• v.16 no.3
• /
• pp.231-237
• /
• 1992

The effects to the corticosteroid dexamethasone(DEX) and(or) estradiol-benzoate(E-B) treated to induction of parturition and birth weights of the young was conducted in 48 pregnant Korean native goats. The animals were divided into 4 goats per each treatment by the time(142, 145 and 148 day of pregnancy) and dosage(DEX 15, 20mg, DEX 8mg＋E-B 10mg and DEX 13mg＋E-B 7.5mg per goat). The results obtained were summarized as follows: 1 The time for induction of parturtion after DEX(15, 20mg) treatment on day 148 of pregnancy was significantly(P<0.01) shorter than 142 and 145 days. There was no significant difference each dosage of DEX on same day of pregnancy. 2. The addition of E-B to DEX treatment compared with DEX alone group at day 142 and 145 of pregnancy were significantly(P<0.01) shorter the time for induction of parturition. However, treatment with DEX along or with E-B on 148 day of pregnancy did not affect the time to induction(about 27 hrs) of parturition between each treatment. 3. The birth weight of kids after parturition was heaviest(P<0.01) on day 148 of pregnancy. However, development and vigor of kids were not significant different between DEX alone treatment and with E-B.

• Journal of Periodontal and Implant Science
• /
• v.30 no.1
• /
• pp.27-39
• /
• 2000

To evaluate the effects of Dexamethasone(Dex), Platelet derived growth factor-BB(PDGF) and combination of Dex and PDGF(DP) on the growth and differentiation of MC3T3-E1 cells, Dex($10^{-7}\;M$) and PDGF(10 ng/ml) in experimental group were added to the cells at the days 5, 10, 15, 20, 25 and examined for cell proliferation activities, DNA synthesis activities, ALP activities and bone nodule formation. The results were as follows : 1. In Dex group, cell proliferation, DNA synthesis and ALP activities were lower until 15 days when compared to the control group. Bone nodules formation were shown at 10 days. 2. In PDGF group, cell proliferation and DNA synthesis activities were higher until 15 days and ALP activities were lower when compared to the control and Dex groups. Bone nodules formation were shown at 20 days. 3. In DP group, cell proliferation and DNA synthesis activities of PDGF were suppressed by Dex and synergistic effects of combination of Dex and PDGF on ALP activities were shown at days 5 when compared to control and Dex groups. Bone nodules formation activities of Dex were suppressed by PDGF.

• IMMUNE NETWORK
• /
• v.14 no.6
• /
• pp.328-332
• /
• 2014

Dexamethasone (Dex) was shown to inhibit the differentiation, maturation, and antigen-presenting function of dendritic cells (DC) when added during DC generation or maturation stages. Here, we examined the direct effects of Dex on MHC-restricted antigen processing. Macrophages were incubated with microencapsulated ovalbumin (OVA) in the presence of different concentrations of Dex for 2 h, and the efficacy of OVA peptide presentation was evaluated using OVA-specific CD8 and CD4 T cells. Dex inhibited both class I- and class II-restricted presentation of OVA to T cells; this inhibitory effect on antigen presentation was much more potent in immature macrophages than in mature macrophages. The presentation of the exogenously added OVA peptide SIINFEKL was not blocked by Dex. In addition, short-term treatment of macrophages with Dex had no discernible effects on the phagocytic activity, total expression levels of MHC molecules or co-stimulatory molecules. These results demonstrate that Dex inhibits intracellular processing events of phagocytosed antigens in macrophages.

• Journal of Aquaculture
• /
• v.7 no.2
• /
• pp.123-134
• /
• 1994

Effects of glucocorticosteroids (GCS) on the thymus and peripheral lymphocytes of Nile tilapia. Oreochromis niloticus were examined. Young fish (5-7g) were injected into intraperitonial cavity with various dose of dexamethasone (DEX) or hydrocortisone (HC). Histology of thymus and thymocyte counts in treated fish were compared to normal ones. The results showed that in vivo adminstration of DEX or HC induced weight loss of thymus and reduction of thymocytes, and both of these were dose and time dependent. In vivo treatment of thymocytes with 10 mM DEX or 10 mM HC for 12hrs caused DNA fragmentation. Both drugs could split the DNA into fragments of about 180-200 base paire multiples. There was no change in granulocytes of peripheral blood due to the treatment of DEX or HC with various length of time. In contrast, treatment of DEX or HC for 2-3 days decresed number of peripheral lymphocytes. The results indicate that the thymocytes and circulating lymphocytes would respond to GCS depending on several factors, such as nature of the hormone, dose, and duration of treatment.

• Journal of the Korea Institute of Information Security & Cryptology
• /
• v.29 no.1
• /
• pp.45-55
• /
• 2019

DEX file and share objects (also known as the SO file) are important components that define the behaviors of an Android application. DEX file is implemented in Java code, whereas SO file under ELF file format is implemented in native code(C/C++). The two layers - Java and native can communicate with each other at runtime. Malicious applications have become more and more prevalent in mobile world, they are equipped with different evasion techniques to avoid being detected by anti-malware product. To avoid static analysis, some applications may perform malicious behavior in native code that is difficult to analyze. Existing researches fail to extract the call relationship which includes both Java code and native code, or can not analyze multi-DEX application. In this study, we design and implement a system that effectively extracts the call relationship between Java code and native code by analyzing DEX file and SO file of Android application.

• Osong Public Health and Research Perspectives
• /
• v.9 no.6
• /
• pp.334-339
• /
• 2018

Objectives: Human rhinoviruses (HRVs) are the major cause of the common cold. Currently there is no registered, clinically effective, antiviral chemotherapeutic agent to treat diseases caused by HRVs. In this study, the antiviral activity of dexamethasone (DEX) against HRV1B was examined. Methods: The anti-HRV1B activity of DEX was assessed by sulforhodamine B assay in HeLa cells, and by RT-PCR in the lungs of HRV1B-infected mice. Histological evaluation of HRV1B-infected lungs was performed and a histological score was given. Anti-HRV1B activity of DEX via the glucocorticoid receptor (GCR)-dependent autophagy activation was assessed by blocking with chloroquine diphosphate salt or bafilomycin A1 treatment. Results: In HRV1B-infected HeLa cells, treatment with DEX in a dose-dependent manner, resulted in a cell viability of > 70% indicating that HRV1B viral replication was reduced by DEX treatment. HRV1B infected mice treated with DEX, had evidence of reduced inflammation and a moderate histological score. DEX treatment showed antiviral activity against HRV1B via GCR-dependent autophagy activation. Conclusion: This study demonstrated that DEX treatment showed anti-HRV1B activity via GCR-dependent autophagy activation in HeLa cells and HRV1B infected mice. Further investigation assessing the development of topical formulations may enable the development of improved DEX effectiveness.

• Journal of Periodontal and Implant Science
• /
• v.29 no.2
• /
• pp.277-289
• /
• 1999

The ultimate aim of periodontal treatment is periodontal regeneration, which necessiates the regeneration of bone tissues. To evaluate the effects of Dex growth and differentiation of MC3T3-E1 cells, cells were seeded in alpha-modified eagle medium containing 10% fetal bovine serum, 10mM beta-glycerophosphate , $50{\mu}g/ml$ of ascorbic acid, with or without $10^{-7}M$ Dex and examined cell proliferation activities, alkaline phosphatase activities, and bone nodule formation until 25days. The results were as follows : 1. In Dex group, cell proliferation activities were lower until 15 days compared to control group. Bone nodules formation were showed at 10 days. 2. In the time-response effect, ALP activities were increased until the 10 days in control groups thereafter decreased and ALP activities of Dex group were lower aspect than control group until the 10 days In this study, bone nodule formation of osteoblast-like cells were accelerated by Dex and cell proliferation activities, ALP activity of Dex group showed lower than control group. Dex was considered that it did suppress initial growth, but accerelate mineralization of osteoblast-like cells.

• Journal of Dental Anesthesia and Pain Medicine
• /
• v.16 no.1
• /
• pp.25-29
• /
• 2016

Background: The most important reason for pre-operative administration of medication is to reduce anxiety. Alleviation of fear and anxiety about surgery enables patients to remain comfortable during treatment. Dexmedetomidine (DEX) is a fast-acting drug that is used as a premedication in different circumstances because it has sedative and anti-anxiolytic effects, and stable hemodynamics. It also has the advantage of intranasal administration. The aim of this study was to investigate the effects and hemodynamic stability of DEX by retrospectively analyzing cases in which DEX was administered nasally as a premedication. Methods: Ten patients treated at Dankook University Dental Hospital, recruited between February and April 2015, received intranasal delivery of $2{\mu}g/kg$ DEX, 30 minutes prior to general anesthesia. Anesthesia records of anxiety, blood pressure, respiration, pulse, estimated arterial oxygen saturation ($SpO_2$), and partial pressure, or maximum concentration, of carbon dioxide ($ETCO_2$) were analyzed. Results: Administration of DEX prior to a general anesthetic effectively relieved anxiety. Respiratory depression, the most severe adverse effect of other sedatives, was not observed. Hemodynamic stability under general anesthesia was maintained during treatment and a reduction in emergence delirium was observed upon completion of treatment. Conclusions: Premedication administration of DEX is safe for pediatric patients undergoing dental treatment under general anesthesia.

• Review of KIISC
• /
• v.34 no.1
• /
• pp.53-59
• /
• 2024

블록체인 기술의 발전과 중앙집중형 금융서비스의 취약성과 불신에 대한 우려가 커지면서 탈중앙화 금융(DeFi)과 탈중앙화 거래소(DEX)가 유망한 대안으로 떠올랐다. 본 논문에서는 특히 Uniswap에 초점을 맞춰 DeFi 내의 과제와 문제를 살펴본다. 우리는 DeFi 및 DEX의 현재 상태에 대한 배경 지식을 제공하여 MEV(Maximal Extractable Value) 공격에 대한 취약성을 강조한다. 우리의 접근 방식에는 MEV 공격 패턴을 식별하고 분석하기 위한 Uniswap에 구조 분석이 포함된다. 이 연구는 DEX 보안을 강화하고 MEV 위험을 완화하기 위한 귀중한 지침을 제공하여 DeFi 생태계의 이해관계자에게 필수적인 리소스 역할을 한다.

• The Korean Journal of Pain
• /
• v.27 no.4
• /
• pp.345-352
• /
• 2014

Background: Epidural administration of dexamethasone has been suggested for pain control after minor orthopedic surgery. This study was conducted to assess its efficacy after such surgery, combined or not to IV dipyrone, IV parecoxibe or their combination. Methods: 91 patients were randomly assigned to seven groups. Patients were submitted to spinal bupivacaine anesthesia combined to epidural administration of either 10 ml saline or 10 mg dexamethasone diluted to 10-ml volume. Patients also received 10 ml IV saline or 1 gr dipyrone and/or 40 mg parecoxibe diluted to 10 ml with saline. Control group (CG) received epidural and IV saline. Dexamethasone group (DexG) received epidural dexamethasone and IV saline. Dipyrone group (DipG) received epidural saline and IV dipyrone. Dex-Dip G received epidural dexamethasone and IV dipyrone. Parecoxibe group (ParG) received epidural saline and IV parecoxibe. Dex-ParG received epidural dexamethasone and IV parecoxibe. Finally, Dex-Dip-ParG received epidural dexamethasone and IV dipyrone plus IV parecoxibe. Results: The CG expressed 4h of analgesia and sooner requested pain killer. DexG was similar to DipG or ParG or Dex-ParG (7-hours), and they requested less ketoprofen compared to the CG (P < 0.05). However, the Dex-DipG and the Dex-Dip-ParG resulted in longer time to demand pain killer (17-hours) and less ketoprofen consumption in 24-hours (P < 0.002). Adverse effects were similar among groups. Conclusions: The analgesia secondary to epidural dexamethasone was enhanced by IV dipyrone, while no effects were observed by the addition of IV parecoxibe.